Journey Medical Corp (DERM) stock
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3024% below fair value
$4.33−0.06 (-1.37%)
Close on Nov 13, 2026Market cap $122.21MP/E –Yield –
Journey Medical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Journey Medical's enterprise value was $118.45M on Nov 11, 2026, against $186.17M a year earlier. Over the last 5 years it ranged from -$5.51M to $201.34M, with a median of $76.23M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $118.45M | -33.4% |
| 2025 | Dec 31, 2025 | $177.87M | +138.7% |
| 2024 | Dec 31, 2024 | $74.53M | -2.2% |
| 2023 | Dec 29, 2023 | $76.23M | +363.7% |
| 2022 | Dec 30, 2022 | $16.44M | – |
| 2021 | Dec 31, 2021 | -$4.68M | – |
See a number that looks wrong?